ОбзорГрафикНовостиTraderScreen

Citi Bonus Zert NVDA 25.09.2024/  DE000KJ4A406  /

Frankfurt Zert./CITI
29.05.2024  14:04:43 Изменение+1.420 Бид14:08:16 Предложение- Базовый актив Цена исполнения Дата истечения Тип опциона
665.070EUR +0.21% 664.780
Величина цены спроса: 300		 -
Величина цены предложения: -		 NVIDIA Corporation - USD 25.09.2024 Call
GlobeNewswire 14:06 Kabosu has passed on! Meet NOTINU, the new face of dog memes in the crypto industry
GlobeNewswire 14:05 Two Six Technologies Opens New Office at Coppermine Commons in Herndon, Virginia
GlobeNewswire 14:05 MaxCyte to Participate in William Blair 44th Annual Growth Stock Conference
GlobeNewswire 14:05 Bridger Aerospace Set to Join Russell 3000®, Russell 2000® and Russell Microcap® Indexes
GlobeNewswire 14:05 Alvotech to Participate in Jefferies Healthcare Conference in New York, June 5-6, 2024
GlobeNewswire 14:05 GBCI rankings revealed for 2024: the Netherlands and the UK placed among the 10 easiest countries to...
GlobeNewswire 14:03 American Rare Earths Announces Zircon Co-Product Potential
TeleTrader 14:01 German inflation up from 2.2% to 2.4% in May
GlobeNewswire 14:01 The insurance industry has big ambitions for analytics but struggles to realize benefits as progress...
GlobeNewswire 14:01 Tristan Schukraft’s Tryst Hospitality Acquires DS Tequila in Chicago’s Northalsted
GlobeNewswire 14:00 Intra-Cellular Therapies to Present at the Jefferies Global Healthcare Conference
GlobeNewswire 14:00 Erasca to Present at Upcoming Investor Conferences in June
GlobeNewswire 14:00 Tonix Pharmaceuticals Announces Two Oral Presentations and One Poster Presentation Involving TNX-150...
GlobeNewswire 14:00 AYR Partners with Iconic Kowloon Restaurant to Launch Limited Edition LEVIA Kowloon Mai Tai THC Infu...
GlobeNewswire 14:00 Canary Medical’s Smart Spine Lumbar Cartridge Granted FDA “Breakthrough Device” Designation
GlobeNewswire 14:00 BioAtla to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire 14:00 GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer
GlobeNewswire 14:00 Clover Health Announces Counterpart Health, a New SaaS and Tech Enabled Services Solution to Bring t...
GlobeNewswire 14:00 Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure o...
GlobeNewswire 14:00 Indaptus Therapeutics to Present New Cohort Data Confirming Original “Pulse-Prime” Hypothesis Via Ph...
GlobeNewswire 14:00 Intercept Announces New Data to be Presented at the European Association for the Study of the Liver ...
GlobeNewswire 14:00 Gentex Announces Second Quarter 2024 Cash Dividend
GlobeNewswire 14:00 Cerence to Power Zeekr Multilingual AI Assistant
GlobeNewswire 14:00 Collegium to Participate in Jefferies Global Healthcare Conference
GlobeNewswire 14:00 KALA BIO to Present at Jefferies Global Healthcare Conference